Boule Diagnostics (Sweden) Market Value

BOUL Stock  SEK 7.00  0.38  5.15%   
Boule Diagnostics' market value is the price at which a share of Boule Diagnostics trades on a public exchange. It measures the collective expectations of Boule Diagnostics AB investors about its performance. Boule Diagnostics is selling for under 7.00 as of the 28th of November 2024; that is 5.15 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 6.78.
With this module, you can estimate the performance of a buy and hold strategy of Boule Diagnostics AB and determine expected loss or profit from investing in Boule Diagnostics over a given investment horizon. Check out Boule Diagnostics Correlation, Boule Diagnostics Volatility and Boule Diagnostics Alpha and Beta module to complement your research on Boule Diagnostics.
Symbol

Please note, there is a significant difference between Boule Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Boule Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boule Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Boule Diagnostics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boule Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boule Diagnostics.
0.00
10/29/2024
No Change 0.00  0.0 
In 30 days
11/28/2024
0.00
If you would invest  0.00  in Boule Diagnostics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Boule Diagnostics AB or generate 0.0% return on investment in Boule Diagnostics over 30 days. Boule Diagnostics is related to or competes with GomSpace Group, Hansa Biopharma, Zealand Pharma, BioInvent International, and Orphazyme. Boule Diagnostics AB , a diagnostics company, develops, manufactures, and markets instruments and consumable products fo... More

Boule Diagnostics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boule Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boule Diagnostics AB upside and downside potential and time the market with a certain degree of confidence.

Boule Diagnostics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Boule Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boule Diagnostics' standard deviation. In reality, there are many statistical measures that can use Boule Diagnostics historical prices to predict the future Boule Diagnostics' volatility.
Hype
Prediction
LowEstimatedHigh
3.417.0010.59
Details
Intrinsic
Valuation
LowRealHigh
2.696.289.87
Details
Naive
Forecast
LowNextHigh
3.416.9910.58
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.516.987.46
Details

Boule Diagnostics Backtested Returns

Boule Diagnostics secures Sharpe Ratio (or Efficiency) of -0.0839, which signifies that the company had a -0.0839% return per unit of risk over the last 3 months. Boule Diagnostics AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Boule Diagnostics' Risk Adjusted Performance of (0.01), mean deviation of 2.58, and Standard Deviation of 3.55 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.89, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Boule Diagnostics are expected to decrease slowly. On the other hand, during market turmoil, Boule Diagnostics is expected to outperform it slightly. At this point, Boule Diagnostics has a negative expected return of -0.3%. Please make sure to confirm Boule Diagnostics' maximum drawdown, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to decide if Boule Diagnostics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

Boule Diagnostics AB has no correlation between past and present. Overlapping area represents the amount of predictability between Boule Diagnostics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boule Diagnostics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Boule Diagnostics price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test-0.25
Residual Average0.0
Price Variance0.05

Boule Diagnostics lagged returns against current returns

Autocorrelation, which is Boule Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Boule Diagnostics' stock expected returns. We can calculate the autocorrelation of Boule Diagnostics returns to help us make a trade decision. For example, suppose you find that Boule Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Boule Diagnostics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Boule Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Boule Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Boule Diagnostics stock over time.
   Current vs Lagged Prices   
       Timeline  

Boule Diagnostics Lagged Returns

When evaluating Boule Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Boule Diagnostics stock have on its future price. Boule Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Boule Diagnostics autocorrelation shows the relationship between Boule Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Boule Diagnostics AB.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Boule Stock Analysis

When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.